Karen Talmadge, Ph.D., co-founded and funded Kyphon Inc., a minimally-invasive spine medical device company, and has served as a member of its Board of Directors since the company's inception in 1994. Dr. Talmadge also served as Kyphon's Chief Science Officer since June 2003, and as its Executive Vice President since November 1998. In Kyphon's start-up phase from 1994-1998, she was the company's President, Chief Executive Officer and Treasurer. Dr. Talmadge also currently serves on the Boards of Directors of three start-up medical device companies, Cartilix, Gynesonics and VeraLight; the Spine Masters Institute of the North American Spine Society; and the American Diabetes Association. She is also the co-chair of the biotechnology review committee of the Life Sciences Angels. Prior to Kyphon, Dr. Talmadge worked at California Biotechnology, now Scios Inc., for ten years, where she held numerous research and business positions, including Vice President, Research and Development, for its wholly owned subsidiary, Metabolic Biosystems. She conducted post-doctoral research at Harvard University and Cold Spring Harbor Laboratory. She holds a Ph.D. in Biochemistry from Harvard University, and an A.B. cum laude in Biology from Bryn Mawr College.
-
